Cargando…
Virtual disclosure of preclinical Alzheimer's biomarkers: Preliminary experiences
Autores principales: | Erickson, Claire M., Chin, Nathaniel A., Coughlin, DaRae M., Conway, Camille E., Rosario, Hannah L., Johnson, Sterling C., Clark, Lindsay R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273122/ https://www.ncbi.nlm.nih.gov/pubmed/33960399 http://dx.doi.org/10.1111/jgs.17184 |
Ejemplares similares
-
Feasibility of virtual Alzheimer's biomarker disclosure: Findings from an observational cohort
por: Erickson, Claire M., et al.
Publicado: (2023) -
The Wisconsin Alzheimer's Institute Dementia Diagnostic Clinic Network: A community of practice to improve dementia care
por: Mora Pinzon, Maria, et al.
Publicado: (2022) -
Research Participant Interest in Alzheimer’s Disease Biomarker Disclosure
por: Erickson, Claire, et al.
Publicado: (2020) -
Geriatric home‐based rehabilitation in Australia: Preliminary data from an inpatient bed‐substitution model
por: Loveland, Paula M., et al.
Publicado: (2022) -
Disclosure of preclinical Alzheimer's disease biomarker results in research and clinical settings: Why, how, and what we still need to know
por: Erickson, Claire M., et al.
Publicado: (2021)